Buy Opportunity: Oscar Health Below $14

about 1 month ago

Host

"okay, we've had a pullback in in the health care companies. Why? Because Trump says they charge too much. They make too much money. Oh, shocking. You know, think about health care. Healthcare needs to make the way they make money is by either cutting services or charging you more. One or the other. So, this is Oscar. I love the price slider. Okay. the most traded price uh since the IPO on the average cost of every buyer since IPO are lined up around $14.70. Guess what? You know, you can buy this one under I think 14. We'll look at this chart, but it's literally telling you the point of control since IPO is $14.70. You want to buy under that VWAP volume weighted average price."

The speaker emphasizes a technical opportunity in Oscar Health, noting that the average buyer cost since IPO centers around $14.70. He suggests that buying the stock under $14, potentially around 13.15, could offer a favorable risk/reward profile.

Related Stocks